93 related articles for article (PubMed ID: 21897063)
1. [Current status in and future directions of the treatment of hematological disorders with molecular-targeting agents--Overview].
Kizaki M
Rinsho Ketsueki; 2011 Aug; 52(8):583-6. PubMed ID: 21897063
[No Abstract] [Full Text] [Related]
2. Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
Med Lett Drugs Ther; 2007 Sep; 49(1270):79-80. PubMed ID: 17878890
[No Abstract] [Full Text] [Related]
3. [Programs for continuing medical education: B session 7. Progress in treatment for hematologic diseases].
Higashihara M
Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):717-23. PubMed ID: 24796142
[No Abstract] [Full Text] [Related]
4. [Development and clinical application of novel proteasome inhibitors].
Iida S
Rinsho Ketsueki; 2012 Apr; 53(4):417-25. PubMed ID: 22687975
[No Abstract] [Full Text] [Related]
5. [Feature articles: current status and future direction of the treatment of hematological disorders with molecular-targeting agents (1)].
Kizaki M
Rinsho Ketsueki; 2011 Jul; 52(7):433-7. PubMed ID: 21821973
[No Abstract] [Full Text] [Related]
6. Severe pancytopenia associated with a minor paroxysmal nocturnal haemoglobinuria clone and response to ciclosporin A in a heavily pretreated multiple myeloma patient.
Kulagin A; Lisukov I; Denisova V; Kruchkova I; Sizikova S; Gilevich A; Pronkina N; Kozhevnikov V; Kozlov V
Br J Haematol; 2008 Apr; 141(1):122-3. PubMed ID: 18279453
[No Abstract] [Full Text] [Related]
7. [Current treatment strategies with novel agents for multiple myeloma].
Tokuhira M
Rinsho Ketsueki; 2011 Aug; 52(8):587-602. PubMed ID: 21897064
[No Abstract] [Full Text] [Related]
8. [Current status and future perspective of new drugs for hematological malignancies in Japan].
Ogura M
Rinsho Ketsueki; 2007 Oct; 48(10):1442-52. PubMed ID: 17933133
[No Abstract] [Full Text] [Related]
9. [Clinical development of a proteasome inhibitor, bortezomib, for the treatment of myeloma and lymphoma].
Tobinai K
Rinsho Ketsueki; 2007 Jun; 48(6):451-7. PubMed ID: 17633092
[No Abstract] [Full Text] [Related]
10. New treatment options for immune-mediated hematological disorders.
Dierickx D; De Rycke A; Vanderschueren S; Delannoy A
Eur J Intern Med; 2008 Dec; 19(8):579-86. PubMed ID: 19046722
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma study group of JCOG.
Tsukasaki K; Tobinai K; Hotta T; Shimoyama M
Jpn J Clin Oncol; 2012 Feb; 42(2):85-95. PubMed ID: 22147803
[TBL] [Abstract][Full Text] [Related]
12. The emotional consequences of corticosteroid use in hematology: preliminary findings.
McGrath P; Holewa H
J Psychosoc Oncol; 2010; 28(4):335-50. PubMed ID: 20623411
[TBL] [Abstract][Full Text] [Related]
13. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
14. Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.
Tabata R; Tabata C; Tazoh A; Nagai T
Int Immunopharmacol; 2012 Jul; 13(3):242-4. PubMed ID: 22561120
[TBL] [Abstract][Full Text] [Related]
15. Targeting Wnt pathway in lymphoma and myeloma cells.
Schmidt M; Sievers E; Endo T; Lu D; Carson D; Schmidt-Wolf IG
Br J Haematol; 2009 Mar; 144(5):796-8. PubMed ID: 19036118
[No Abstract] [Full Text] [Related]
16. Battling the hematological malignancies: the 200 years' war.
Lichtman MA
Oncologist; 2008 Feb; 13(2):126-38. PubMed ID: 18305057
[TBL] [Abstract][Full Text] [Related]
17. Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma.
Kasili EG
East Afr Med J; 1976 Sep; 53(9):554-9. PubMed ID: 1009883
[No Abstract] [Full Text] [Related]
18. Myeloma researchers gain genome, new targets, and new concerns.
Brower V
J Natl Cancer Inst; 2011 Jul; 103(14):1082-5. PubMed ID: 21737696
[No Abstract] [Full Text] [Related]
19. The spleen in hematologic disorders.
Ito K; Mitchell DG
JBR-BTR; 2000 Aug; 83(4):205-6. PubMed ID: 11126793
[No Abstract] [Full Text] [Related]
20. Idiopathic thrombocytopenic purpura associated with Crohn's disease.
Baudard M; Molina T; Benfiguig K; Bethoux JP; Zittoun R
Haematologica; 1998 Jan; 83(1):92-3. PubMed ID: 9542329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
